Facility #1

Columbia, Maryland 21044

0 studies enrolling now · 1 studies all time

What they study most

Breast Cancer

Studies at this site

• Study to Evaluate the Efficacy and Safety of Eribulin Mesylate Administered Biweekly (Q2W) for Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Metastatic Breast Cancer — Completed